MR. CHARLES TOWNSEND KING M.D. NPI 1871591388

NPI Details

MR. Charles Townsend King, M.D. is an urology in Ocala, FL with 47 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. MR. Charles Townsend King, M.D. NPI is 1871591388. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE
Graduation Year:1979

The provider's business location address is:

2850 SE THIRD COURT
OCALA, FL
ZIP 34471-118
Phone: (352) 732-6474
Fax: (352) 732-7205

The NPI 1871591388 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Urinalysis, manual test (HCPCS:81002)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Simple bladder irrigation and/or instillation (HCPCS:51700)
• Protein test for diagnosis and monitoring of bladder cancer (HCPCS:86386)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Injection, tobramycin sulfate, up to 80 mg (HCPCS:J3260)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Biopsy of prostate gland (HCPCS:55700)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• 3d radiographic procedure with computerized image postprocessing (HCPCS:76377)
• Injection, vancomycin hcl, 500 mg (HCPCS:J3370)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)

The enumeration date for this NPI number is 7/8/2005 and was last updated on 8/3/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.